Molecular pathology of ALS: what we currently know and what important information is still missing

N Jankovska, R Matej - Diagnostics, 2021 - mdpi.com
Despite an early understanding of amyotrophic lateral sclerosis (ALS) as a disease affecting
the motor system, including motoneurons in the motor cortex, brainstem, and spinal cord …

Use of biomarkers in ALS drug development and clinical trials

N Bakkar, A Boehringer, R Bowser - Brain research, 2015 - Elsevier
The past decade has seen a dramatic increase in the discovery of candidate biomarkers for
ALS. These biomarkers typically can either differentiate ALS from control subjects or predict …

Blood biomarkers in ALS: challenges, applications and novel frontiers

E Sturmey, A Malaspina - Acta Neurologica Scandinavica, 2022 - Wiley Online Library
Amyotrophic lateral sclerosis (ALS) is the most common motor neuron disease among
adults. With diagnosis reached relatively late into the disease process, extensive motor cell …

Unsupervised machine learning identifies distinct ALS molecular subtypes in post-mortem motor cortex and blood expression data

H Marriott, R Kabiljo, GP Hunt, AA Khleifat… - Acta neuropathologica …, 2023 - Springer
Amyotrophic lateral sclerosis (ALS) displays considerable clinical and genetic
heterogeneity. Machine learning approaches have previously been utilised for patient …

[HTML][HTML] State of the art and the dark side of amyotrophic lateral sclerosis

A Musarò - World journal of biological chemistry, 2010 - ncbi.nlm.nih.gov
Amyotrophic lateral sclerosis (ALS) is a disorder that involves the degeneration of motor
neurons, muscle atrophy, and paralysis. In a few familiar forms of ALS, mutations in the …

Biochemical markers in CSF of ALS patients

SD Sussmuth, J Brettschneider… - Current medicinal …, 2008 - ingentaconnect.com
Amyotrophic lateral sclerosis (ALS) is the most common form of motor neuron diseases
(MND) characterized by progressive selective degeneration of motor neurons. Although …

Destination amyotrophic lateral sclerosis

M Keon, B Musrie, M Dinger, SE Brennan… - Frontiers in …, 2021 - frontiersin.org
Amyotrophic Lateral Sclerosis (ALS) is a prototypical neurodegenerative disease
characterized by progressive degeneration of motor neurons both in the brain and spinal …

[HTML][HTML] Lessons of ALS imaging: pitfalls and future directions—a critical review

P Bede, O Hardiman - NeuroImage: Clinical, 2014 - Elsevier
Background While neuroimaging in ALS has gained unprecedented momentum in recent
years, little progress has been made in the development of viable diagnostic, prognostic and …

Targeted sequencing panels in Italian ALS patients support different etiologies in the ALS/FTD continuum

A Bartoletti-Stella, V Vacchiano, S De Pasqua… - Journal of …, 2021 - Springer
Abstract Background 5–10% of amyotrophic lateral sclerosis (ALS) patients presented a
positive family history (fALS). More than 30 genes have been identified in association with …

Pathophysiological and diagnostic implications of cortical dysfunction in ALS

N Geevasinga, P Menon, PH Özdinler… - Nature Reviews …, 2016 - nature.com
Cortical dysfunction—specifically, the development of hyperexcitability—seems to be an
early and intrinsic feature of sporadic and familial amyotrophic lateral sclerosis (ALS) …